Immunologist Alexander Rudensky, Shimon Sakaguchi of Osaka University in Japan, and Fred Ramsdell of the Parker Institute for Cancer Immunotherapy in San Francisco won the 2017 Crafoord Prize.
They won the honour for “their discoveries relating to regulatory T cells, which counteract harmful immune reactions in arthritis and other autoimmune diseases.”
About Alexander Rudensky
• Alexander Rudensky is an immunologist at Memorial Sloan Kettering Cancer Center.
• He is known for his research on regulatory T cells and the transcription factor Foxp3.
• He earned his PhD from the Gabrichevsky Research Institute of Epidemiology and Microbiology, Moscow.
• He completed his postdoctoral work at the Yale School of Medicine.
• At present, he is the Chair of the Immunology Program and Director of the Ludwig Center at Memorial Sloan Kettering.
About Shimon Sakaguchi
• Shimon Sakaguchi is an immunologist.
• He is best known for the discovery of regulatory T cells and to describe their role in the immune system.
About Crafoord Prize
• The Crafoord Prize is an annual science prize.
• It was established by Holger Crafoord, a Swedish industrialist, and his wife Anna-Greta Crafoord, in 1980.
• The prize is administered by the Royal Swedish Academy of Sciences.
• It is awarded in four categories: astronomy and mathematics, geosciences, biosciences, with particular emphasis on ecology, and polyarthritis.
• The prize money is 6 million Krona.
• The first woman to be awarded with the prestigious prize was astronomer Andrea Ghez.
What: Won 2017 Crafoord Prize
DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.